Julie So-Young Kim insider trades
Open-market stock purchases and sales by Julie So-Young Kim, President and CEO at Takeda Pharmaceutical Co Ltd, from SEC Form 4 filings since Apr 27, 2026.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jul 1, 2026 | TAK Takeda Pharmaceutical Co Ltd | Bought (not open market) | — |
| Jul 1, 2026 | TAK Takeda Pharmaceutical Co Ltd | Bought (not open market) | — |
| Jul 1, 2026 | TAK Takeda Pharmaceutical Co Ltd | Bought (not open market) | — |
| Jul 1, 2026 | TAK Takeda Pharmaceutical Co Ltd | Bought (not open market) | — |
| Apr 27, 2026 | TAK Takeda Pharmaceutical Co Ltd | Bought (not open market) | — |
Companies traded
- TAK Takeda Pharmaceutical Co Ltd: other filings, last Jul 1, 2026